Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

Homecompany2,4-Difluorophenyl-(4-piperidinyl)methanone oxime hydrochloride 98%
2,4-Difluorophenyl-(4-piperidinyl)methanone oxime hydrochloride
2,4-Difluorophenyl-(4-piperidinyl)methanone oxime hydrochloride
2,4-Difluorophenyl-(4-piperidinyl)methanone oxime hydrochloride

2,4-Difluorophenyl-(4-piperidinyl)methanone oxime hydrochloride 98%

Price Get Latest Price
Packge 1MT1kg5kg10kg25kg
  • Min. Order:1MT
  • Time:2023-09-30

Product Details

  • Product Name2,4-Difluorophenyl-(4-piperidinyl)methanone oxime hydrochloride
  • CAS No.135634-18-3
  • EINECS No.603-927-4
  • MFC12H15ClF2N2O
  • MW276.71
  • Appearancepowder to crystalWhite to Almost white
  • storage temp. under inert gas (nitrogen or Argon) at 2-8°C

Company Profile Introduction

Molecraft LifeSciences is actively involved in research and development and production of active pharmaceutical ingredients (API’s), intermediates(advance Intermediates), metabolites , Pharmaceutical Impurities and related products etc.

Molecraft is involved in R&D of products ranging from milligrams scale to kilo scales, using chemical, bio-synthesis, enzymatic and fermentation processes.

At Molecraft, Our motto is not only to make and supply molecules, but also to provide cost-efficient solutions to our clients in the fine chemical and pharmaceutical industries.

We understand the importance of delivering the products in time, to meet such tight timelines we also represent many overseas producers for distribution of API and related products. Our esteemed clients are top research-based multinational pharma and bio companies, research institutions and generic drug manufacturers.

MOLECRAFT LIFE SCIENCES PVT LTD

2Y Telangana India
  • Since:2020-09-01
  • Address: 10-3-311/13/3/F-A. PLOT NO. 32, ROAD NO. 2, CASTLE HILLS, MASAB TANK, HYDERABAD - 500 057, TELANGAN
INQUIRY